April 17 – 22, San Diego
EPO will attend the AACR Annual Meeting 2026 in San Diego, CA
Meet us at the AACR and gain insights on how EPO’s services can accelerate your preclinical oncology programs. Watch out for our posters:
Enhanced in vivo and ex vivo analysis enables deeper characterization of humanized mouse models for immuno-oncology research
Presented by Maria Stecklum
Poster #714 - Board 4 - Section 29 - Session: Molecular Pathology
4/19/2026 at 2PM – 5PM
Humanized mouse models 2.0 - Improved preclinical evaluation
of novel immune cell therapies, check point inhibitors, and immune cell
engagers by excluding false positive or negative results
Presented by Maria Stecklum
Poster #3385 - Board 15 - Section 27 – Session: Humanized Mouse Models
4/20/2026 at 2PM – 5PM
Modeling the multicellular blood-brain barrier with a
PDX-derivedglioblastoma microenvironment: comparing human and mouse
biochip systems for tumor heterogeneity and drug response
Presented by Amélie Paillereau (Dynamic42); First author Michelle Zimmer (EPO)
Poster #3401 - Board 6 - Section 28 – Session: In Vitro Models 1: 2D and 3D
4/20/2026 at 2PM – 5PM
Repurposing PARP inhibitors in molecularly defined subgroups of peritoneal metastatic colorectal cancer (pmCRC): Preclinical analysis of patient-derived xenograft (PDX) models
Presented by Antje Wengner
Poster #4476 - Board 24 - Section 13 – Session: Drug Combinations, Repurposing, and Differentiation
4/21/2026 at 9AM – 12PM